Efficacy and Safety of HMR1766 in Patients With Fontaine Stage II Peripheral Arterial Disease

NCT00443287 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

553

Enrollment

INDUSTRY

Sponsor class

Conditions

Intermittent Claudication

Interventions

DRUG: ataciguat (HMR1766)
DRUG: placebo
DRUG: cilostazol

Sponsor

Sanofi